The company developing novel biologics therapies targeting key components of the immune system for the treatment of cancers of unmet need. Shares of Sensei Biotherapeutics are up 4% in pre-market trade on Wednesday.įor More Such Health News, visit . Sensei Biotherapeutics is a clinical-stage biotechnology company specializing in the field of next-generation cancer immunotherapies. Sensei Biotherapeutics plans to file an IND during the first half of 2023. The company noted that experiments in a mouse tumor model showed a significant increase in the production of anti-tumor CD8+ T cells among animals treated with a combination of SNS-101 and anti-PD-1 antibodies compared with PD-1 alone. SNS-101 also displayed a favorable pharmacokinetic profile in non-human primates compared with a clinical-stage, pH-independent VISTA antibody. The company said these preclinical data show that its conditionally active, pH-selective antibody successfully overcomes pharmacokinetic issues associated with targeting the VISTA immune checkpoint, including target-mediated drug disposition and cytokine release syndrome, in these models. (SNSE) reported preliminary preclinical data from mouse and non-human primate studies of SNS-101, a monoclonal antibody targeting the immune checkpoint VISTA. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.(RTTNews) - Sensei Biotherapeutics, Inc. NASDAQ data is at least 15 minutes delayed. NYSE and AMEX data is at least 20 minutes delayed. Visit to get our data and content for your mobile app or website. Visit Performance Disclosure for information about the performance numbers displayed above. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. The monthly returns are then compounded to arrive at the annual return. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. These returns cover a period from Januthrough September 12, 2022. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.51% per year. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. and Morningstar, Inc.Ĭopyright 2022 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606Īt the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. Forbes Media, LLC Investor's Business Daily, Inc. (NASDAQ: SNSE), an immunotherapy company focused on the discovery and development of next generation therapeutics for cancer, today announced that John Celebi, president and chief executive officer, will present at the Jefferies Healthcare Conference, being held in New York. Each of the company logos represented herein are trademarks of Microsoft Corporation Dow Jones & Company Nasdaq, Inc. BOSTON, (GLOBE NEWSWIRE) - Sensei Biotherapeutics, Inc. This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Zacks Style Scores Education - Learn more about the Zacks Style Scores That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style. As you might remember from your school days, an A, is better than a B a B is better than a C a C is better than a D and a D is better than an F.Īs an investor, you want to buy stocks with the highest probability of success. Within each Score, stocks are graded into five groups: A, B, C, D and F. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score. The scores are based on the trading styles of Value, Growth, and Momentum. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style. The Style Scores are a complementary set of indicators to use alongside the Zacks Rank.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |